PRESS RELEASE published on 02/26/2024 at 14:00, 2 years 2 months ago FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM) FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRIEF published on 02/26/2024 at 14:00, 2 years 2 months ago FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™ FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
PRESS RELEASE published on 02/17/2024 at 01:10, 2 years 2 months ago FSD Pharma Announces US ATM Offering FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
PRESS RELEASE published on 02/06/2024 at 13:00, 2 years 2 months ago Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
PRESS RELEASE published on 01/29/2024 at 22:30, 2 years 3 months ago FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
PRESS RELEASE published on 01/16/2024 at 13:30, 2 years 3 months ago Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics. Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
PRESS RELEASE published on 12/23/2023 at 01:45, 2 years 4 months ago FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
PRESS RELEASE published on 12/05/2023 at 15:00, 2 years 4 months ago FSD Pharma Inc. Announces Closing of Private Placement FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
PRESS RELEASE published on 11/30/2023 at 14:30, 2 years 5 months ago FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities
PRESS RELEASE published on 11/28/2023 at 15:00, 2 years 5 months ago Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness
Published on 05/05/2026 at 01:59, 4 hours 40 minutes ago Tolmer Yields >100,000 g/t Silver Trial Gravity Concentrate
Published on 05/04/2026 at 23:55, 6 hours 44 minutes ago Avant Brands Announces Voting Results from Its 2026 Annual General and Special Meeting of Shareholders
Published on 05/04/2026 at 23:01, 7 hours 38 minutes ago Copper Road Announces Closing of Non-Brokered Private Placement
Published on 05/04/2026 at 23:00, 7 hours 39 minutes ago PJX Resources Adopting Semi-Annual Financial Reporting ("SAR")
Published on 05/04/2026 at 22:50, 7 hours 49 minutes ago IBC Advanced Alloys Announces Amendment of Existing Credit Facility
Published on 05/05/2026 at 05:05, 1 hour 33 minutes ago Pinecone Expands in Europe with New Frankfurt Cloud Region, Delivering the Knowledge Infrastructure for AI to Central European Enterprises
Published on 05/05/2026 at 05:00, 1 hour 38 minutes ago ADTRAN Holdings, Inc. reports first quarter 2026 financial results
Published on 05/05/2026 at 05:00, 1 hour 38 minutes ago Adtran Networks SE announces results for Q1 2026
Published on 05/05/2026 at 02:42, 3 hours 56 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus secures strategic partnership with Boral to deliver one of Australia’s largest logistics precincts
Published on 05/05/2026 at 02:34, 4 hours 4 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: March 2026 quarter update and Macquarie Australia Conference Presentation
Published on 05/04/2026 at 20:57, 9 hours 41 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 05/04/2026 at 17:59, 12 hours 39 minutes ago Saint-Gobain has signed an agreement for the sale of its distribution business in Brazil
Published on 05/04/2026 at 17:38, 13 hours ago Reporting on share buyback transactions carried out between April 29 and April 30, 2026